ArticleClinical rheumatology2012
Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs.
Jing Tan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled itcites it